Intravitreal dexamethasone effect on intravitreal vancomycin elimination in endophthalmitis

Susanna Soon Chun Park, Robert V. Vallar, Chian Huey Hong, Sylviane Von Gunten, Kate Ruoff, Donald J. D'Amico

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Objective: To determine whether intravitreal dexamethasone administration can alter the elimination of intravitreal vancomycin hydrochloride in rabbit eyes with experimental Streptococcus pneumoniae endophthalmitis. Methods: Albino rabbits were infected with an intravitreal inoculum of S pneumoniae (2 x 103 colony-forming units) and randomized after 24 hours to treatment with intravitreal vancomycin hydrochloride (1 mg), alone or in combination with intravitreal dexamethasone (400 μg). For comparison, uninfected eyes were similarly treated. All eyes were enucleated 24, 48, or 72 hours after treatment, and vitreous levels of vancomycin were quantitated using a fluorescence polarizing immunoassay. Results: The half- life of intravitreal vancomycin in infected eyes was prolonged from 48 to 84 hours when eyes were treated with dexamethasone. Conversely, such treatment shortened the half-life in uninfected eyes from 56 to 42 hours. Conclusions: Intravitreal dexamethasone administration reduces the elimination of intravitreal vancomycin in rabbit eyes with pneumococcal endophthalmitis, whereas an opposite effect is noted in uninfected eyes. Clinical Relevance: In patients with eyes having endophthalmitis caused by virulent organisms, the elimination of intravitreal vancomycin may be reduced when intraocular inflammation is minimized with corticosteroid therapy. This may enhance the efficacy of intravitreal vancomycin therapy in treating the infection.

Original languageEnglish (US)
Pages (from-to)1058-1062
Number of pages5
JournalArchives of Ophthalmology
Volume117
Issue number8
StatePublished - Aug 1999
Externally publishedYes

Fingerprint

Endophthalmitis
Vancomycin
Dexamethasone
Rabbits
Half-Life
Therapeutics
Streptococcus pneumoniae
Immunoassay
Pneumonia
Adrenal Cortex Hormones
Stem Cells
Fluorescence
Inflammation

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Park, S. S. C., Vallar, R. V., Hong, C. H., Von Gunten, S., Ruoff, K., & D'Amico, D. J. (1999). Intravitreal dexamethasone effect on intravitreal vancomycin elimination in endophthalmitis. Archives of Ophthalmology, 117(8), 1058-1062.

Intravitreal dexamethasone effect on intravitreal vancomycin elimination in endophthalmitis. / Park, Susanna Soon Chun; Vallar, Robert V.; Hong, Chian Huey; Von Gunten, Sylviane; Ruoff, Kate; D'Amico, Donald J.

In: Archives of Ophthalmology, Vol. 117, No. 8, 08.1999, p. 1058-1062.

Research output: Contribution to journalArticle

Park, SSC, Vallar, RV, Hong, CH, Von Gunten, S, Ruoff, K & D'Amico, DJ 1999, 'Intravitreal dexamethasone effect on intravitreal vancomycin elimination in endophthalmitis', Archives of Ophthalmology, vol. 117, no. 8, pp. 1058-1062.
Park SSC, Vallar RV, Hong CH, Von Gunten S, Ruoff K, D'Amico DJ. Intravitreal dexamethasone effect on intravitreal vancomycin elimination in endophthalmitis. Archives of Ophthalmology. 1999 Aug;117(8):1058-1062.
Park, Susanna Soon Chun ; Vallar, Robert V. ; Hong, Chian Huey ; Von Gunten, Sylviane ; Ruoff, Kate ; D'Amico, Donald J. / Intravitreal dexamethasone effect on intravitreal vancomycin elimination in endophthalmitis. In: Archives of Ophthalmology. 1999 ; Vol. 117, No. 8. pp. 1058-1062.
@article{ddae29f3480a4b909fcde6333e25a9f1,
title = "Intravitreal dexamethasone effect on intravitreal vancomycin elimination in endophthalmitis",
abstract = "Objective: To determine whether intravitreal dexamethasone administration can alter the elimination of intravitreal vancomycin hydrochloride in rabbit eyes with experimental Streptococcus pneumoniae endophthalmitis. Methods: Albino rabbits were infected with an intravitreal inoculum of S pneumoniae (2 x 103 colony-forming units) and randomized after 24 hours to treatment with intravitreal vancomycin hydrochloride (1 mg), alone or in combination with intravitreal dexamethasone (400 μg). For comparison, uninfected eyes were similarly treated. All eyes were enucleated 24, 48, or 72 hours after treatment, and vitreous levels of vancomycin were quantitated using a fluorescence polarizing immunoassay. Results: The half- life of intravitreal vancomycin in infected eyes was prolonged from 48 to 84 hours when eyes were treated with dexamethasone. Conversely, such treatment shortened the half-life in uninfected eyes from 56 to 42 hours. Conclusions: Intravitreal dexamethasone administration reduces the elimination of intravitreal vancomycin in rabbit eyes with pneumococcal endophthalmitis, whereas an opposite effect is noted in uninfected eyes. Clinical Relevance: In patients with eyes having endophthalmitis caused by virulent organisms, the elimination of intravitreal vancomycin may be reduced when intraocular inflammation is minimized with corticosteroid therapy. This may enhance the efficacy of intravitreal vancomycin therapy in treating the infection.",
author = "Park, {Susanna Soon Chun} and Vallar, {Robert V.} and Hong, {Chian Huey} and {Von Gunten}, Sylviane and Kate Ruoff and D'Amico, {Donald J.}",
year = "1999",
month = "8",
language = "English (US)",
volume = "117",
pages = "1058--1062",
journal = "JAMA Ophthalmology",
issn = "2168-6165",
publisher = "American Medical Association",
number = "8",

}

TY - JOUR

T1 - Intravitreal dexamethasone effect on intravitreal vancomycin elimination in endophthalmitis

AU - Park, Susanna Soon Chun

AU - Vallar, Robert V.

AU - Hong, Chian Huey

AU - Von Gunten, Sylviane

AU - Ruoff, Kate

AU - D'Amico, Donald J.

PY - 1999/8

Y1 - 1999/8

N2 - Objective: To determine whether intravitreal dexamethasone administration can alter the elimination of intravitreal vancomycin hydrochloride in rabbit eyes with experimental Streptococcus pneumoniae endophthalmitis. Methods: Albino rabbits were infected with an intravitreal inoculum of S pneumoniae (2 x 103 colony-forming units) and randomized after 24 hours to treatment with intravitreal vancomycin hydrochloride (1 mg), alone or in combination with intravitreal dexamethasone (400 μg). For comparison, uninfected eyes were similarly treated. All eyes were enucleated 24, 48, or 72 hours after treatment, and vitreous levels of vancomycin were quantitated using a fluorescence polarizing immunoassay. Results: The half- life of intravitreal vancomycin in infected eyes was prolonged from 48 to 84 hours when eyes were treated with dexamethasone. Conversely, such treatment shortened the half-life in uninfected eyes from 56 to 42 hours. Conclusions: Intravitreal dexamethasone administration reduces the elimination of intravitreal vancomycin in rabbit eyes with pneumococcal endophthalmitis, whereas an opposite effect is noted in uninfected eyes. Clinical Relevance: In patients with eyes having endophthalmitis caused by virulent organisms, the elimination of intravitreal vancomycin may be reduced when intraocular inflammation is minimized with corticosteroid therapy. This may enhance the efficacy of intravitreal vancomycin therapy in treating the infection.

AB - Objective: To determine whether intravitreal dexamethasone administration can alter the elimination of intravitreal vancomycin hydrochloride in rabbit eyes with experimental Streptococcus pneumoniae endophthalmitis. Methods: Albino rabbits were infected with an intravitreal inoculum of S pneumoniae (2 x 103 colony-forming units) and randomized after 24 hours to treatment with intravitreal vancomycin hydrochloride (1 mg), alone or in combination with intravitreal dexamethasone (400 μg). For comparison, uninfected eyes were similarly treated. All eyes were enucleated 24, 48, or 72 hours after treatment, and vitreous levels of vancomycin were quantitated using a fluorescence polarizing immunoassay. Results: The half- life of intravitreal vancomycin in infected eyes was prolonged from 48 to 84 hours when eyes were treated with dexamethasone. Conversely, such treatment shortened the half-life in uninfected eyes from 56 to 42 hours. Conclusions: Intravitreal dexamethasone administration reduces the elimination of intravitreal vancomycin in rabbit eyes with pneumococcal endophthalmitis, whereas an opposite effect is noted in uninfected eyes. Clinical Relevance: In patients with eyes having endophthalmitis caused by virulent organisms, the elimination of intravitreal vancomycin may be reduced when intraocular inflammation is minimized with corticosteroid therapy. This may enhance the efficacy of intravitreal vancomycin therapy in treating the infection.

UR - http://www.scopus.com/inward/record.url?scp=0032811912&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032811912&partnerID=8YFLogxK

M3 - Article

C2 - 10448749

AN - SCOPUS:0032811912

VL - 117

SP - 1058

EP - 1062

JO - JAMA Ophthalmology

JF - JAMA Ophthalmology

SN - 2168-6165

IS - 8

ER -